Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: Role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein

被引:24
作者
Abdel-Zaher, Ahmed O. [1 ]
Elkoussi, Alaa Eldin A. [1 ]
Abudahab, Lotfy H. [2 ]
Elbakry, Mohammed H. [3 ]
Elsayed, Elsayed Abu-Elwafa [3 ]
机构
[1] Assiut Univ, Fac Med, Dept Pharmacol, Assiut, Egypt
[2] Sohag Univ, Fac Med, Dept Internal Med, Sohag, Egypt
[3] Al Azhar Univ, Fac Med, Dept Pharmacol, Assiut, Egypt
关键词
oxidative stress; losartan; simvastatin; endothelial dysfunction; BLOOD-PRESSURE CONTROL; ENDOTHELIAL DYSFUNCTION; STATINS; THERAPY; RATS; PRAVASTATIN; INHIBITION;
D O I
10.1111/fcp.12020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigated whether simvastatin has antihypertensive activity and can enhance the antihypertensive effect of losartan in hypertensive hypercholesterolemic animals and patients. Hypertension and hypercholesterolemia were induced in rats by L-NAME and cholesterol-enriched diet, respectively. In these animals, repeated administration of simvastatin decreased the systolic blood pressure, enhanced its progressive reductions induced by repeated administration of losartan, and corrected the compromised lipid profile. Concomitantly, repeated administration of simvastatin, losartan, or simvastatin in combination with losartan to these animals increased nitric oxide (NO) production and decreased the elevated serum malondialdehyde (MDA) and high-sensitivity C-reactive protein (hs-CRP) levels. Effects of combined treatment were greater than those of simvastatin or losartan alone. In hypertensive hypercholesterolemic patients, repeated administration of losartan decreased systolic and diastolic blood pressure, increased NO production, and decreased the elevated serum MDA and hs-CRP levels. Addition of simvastatin to losartan therapy enhanced these effects and corrected the compromised lipid profile. Simvastatin inhibited the contractile responses of isolated aortic rings induced by angiotensin II and enhanced the inhibitory effect of losartan on this preparation. l-arginine and acetylcholine enhanced, while L-NAME inhibited the effects of simvastatin, losartan, and their combination on these contractile responses. Thus, simvastatin exerts antihypertensive effect in hypertensive hypercholesterolemic animals and enhances the antihypertensive effect of losartan in hypertensive hypercholesterolemic animals and patients. Besides, its cholesterol-lowering effect, the ability of simvastatin to ameliorate endothelial dysfunction through increasing NO bioavailability and through suppression of oxidative stress and vascular inflammation may play an important role in these effects.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 45 条
[1]   Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein [J].
Abdel-Zaher, Ahmed O. ;
Elkoussi, Alaa Eldin A. ;
Abudahab, Lotfy H. ;
Elbakry, Mohammed H. ;
Elsayed, Elsayed Abu-Elwafa .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (06) :701-711
[2]  
Angelo E., 1992, AM J CARDIOL, V9, P823
[3]   Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia [J].
Borghi, C ;
Prandin, MG ;
Costa, FV ;
Bacchelli, S ;
Degli Esposti, D ;
Ambrosioni, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (04) :549-555
[4]   REACTIVE NITROGEN INTERMEDIATES IN HUMAN NEUROPATHOLOGY - AN OVERVIEW [J].
BROSNAN, CF ;
BATTISTINI, L ;
RAINE, CS ;
DICKSON, DW ;
CASADEVALL, A ;
LEE, SC .
DEVELOPMENTAL NEUROSCIENCE, 1994, 16 (3-4) :152-161
[5]   Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors [J].
Calza, Leonardo ;
Trapani, Filippo ;
Bartoletti, Michele ;
Manfredi, Roberto ;
Colangeli, Vincenzo ;
Borderi, Marco ;
Grossi, Gabriele ;
Motta, Roberto ;
Viale, Pierluigi .
HIV CLINICAL TRIALS, 2012, 13 (03) :153-161
[6]   Impact of simvastatin and losartan on antiinflammatory effect: In vitro study [J].
Chang, Li-Teh ;
Sun, Cheuk-Kwan ;
Chiang, Chiang-Hua ;
Wu, Chiung-Jen ;
Chua, Sarah ;
Yip, Hon-Kan .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) :20-26
[7]  
Del Fiorentino A, 2009, VASC HEALTH RISK MAN, V5, P233
[8]   Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress [J].
Delbosc, S ;
Cristol, JP ;
Descomps, B ;
Mimran, A ;
Jover, B .
HYPERTENSION, 2002, 40 (02) :142-147
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]   Hypertension and Endothelial Dysfunction: Therapeutic Approach [J].
Ghiadoni, Lorenzo ;
Taddei, Stefano ;
Virdis, Agostino .
CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (01) :42-60